nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—CCND1—prostate cancer	0.168	0.401	CbGaD
Arsenic trioxide—AKT1—prostate cancer	0.117	0.279	CbGaD
Arsenic trioxide—CYP1B1—prostate cancer	0.071	0.17	CbGaD
Arsenic trioxide—CYP1B1—Flutamide—prostate cancer	0.0528	0.143	CbGbCtD
Arsenic trioxide—CYP1A1—prostate cancer	0.0383	0.0917	CbGaD
Arsenic trioxide—CYP1B1—Estrone—prostate cancer	0.0382	0.103	CbGbCtD
Arsenic trioxide—CYP3A4—prostate cancer	0.0245	0.0585	CbGaD
Arsenic trioxide—CYP1A1—Flutamide—prostate cancer	0.0232	0.0627	CbGbCtD
Arsenic trioxide—CYP1B1—Mitoxantrone—prostate cancer	0.0227	0.0614	CbGbCtD
Arsenic trioxide—CYP1B1—Estradiol—prostate cancer	0.0219	0.0593	CbGbCtD
Arsenic trioxide—ABCC2—Ethinyl Estradiol—prostate cancer	0.0179	0.0484	CbGbCtD
Arsenic trioxide—CYP1A1—Estrone—prostate cancer	0.0168	0.0453	CbGbCtD
Arsenic trioxide—ABCC2—Conjugated Estrogens—prostate cancer	0.0131	0.0355	CbGbCtD
Arsenic trioxide—CYP1B1—Docetaxel—prostate cancer	0.0131	0.0354	CbGbCtD
Arsenic trioxide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0125	0.0337	CbGbCtD
Arsenic trioxide—ABCB1—Estramustine—prostate cancer	0.0102	0.0275	CbGbCtD
Arsenic trioxide—CYP1B1—Doxorubicin—prostate cancer	0.00977	0.0264	CbGbCtD
Arsenic trioxide—CYP1A1—Estradiol—prostate cancer	0.00963	0.026	CbGbCtD
Arsenic trioxide—ABCC2—Etoposide—prostate cancer	0.00753	0.0204	CbGbCtD
Arsenic trioxide—ABCC2—Docetaxel—prostate cancer	0.00689	0.0186	CbGbCtD
Arsenic trioxide—ABCB1—Cabazitaxel—prostate cancer	0.0067	0.0181	CbGbCtD
Arsenic trioxide—CYP3A4—Bicalutamide—prostate cancer	0.00655	0.0177	CbGbCtD
Arsenic trioxide—ABCB1—Estrone—prostate cancer	0.00655	0.0177	CbGbCtD
Arsenic trioxide—CYP3A4—Estramustine—prostate cancer	0.00609	0.0165	CbGbCtD
Arsenic trioxide—ABCB1—Ethinyl Estradiol—prostate cancer	0.00584	0.0158	CbGbCtD
Arsenic trioxide—CYP3A4—Abiraterone—prostate cancer	0.00543	0.0147	CbGbCtD
Arsenic trioxide—CYP3A4—Flutamide—prostate cancer	0.00543	0.0147	CbGbCtD
Arsenic trioxide—AKT1—penis—prostate cancer	0.00526	0.0968	CbGeAlD
Arsenic trioxide—ABCC2—Doxorubicin—prostate cancer	0.00514	0.0139	CbGbCtD
Arsenic trioxide—ABCB1—Conjugated Estrogens—prostate cancer	0.00428	0.0116	CbGbCtD
Arsenic trioxide—CYP3A4—Cabazitaxel—prostate cancer	0.00401	0.0109	CbGbCtD
Arsenic trioxide—CYP3A4—Estrone—prostate cancer	0.00392	0.0106	CbGbCtD
Arsenic trioxide—ABCB1—Mitoxantrone—prostate cancer	0.00389	0.0105	CbGbCtD
Arsenic trioxide—ABCB1—Estradiol—prostate cancer	0.00376	0.0102	CbGbCtD
Arsenic trioxide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0035	0.00945	CbGbCtD
Arsenic trioxide—ABCB1—Prednisone—prostate cancer	0.00323	0.00874	CbGbCtD
Arsenic trioxide—CYP3A4—Conjugated Estrogens—prostate cancer	0.00257	0.00694	CbGbCtD
Arsenic trioxide—ABCB1—Etoposide—prostate cancer	0.00246	0.00664	CbGbCtD
Arsenic trioxide—CYP3A4—Mitoxantrone—prostate cancer	0.00233	0.00631	CbGbCtD
Arsenic trioxide—CYP3A4—Estradiol—prostate cancer	0.00225	0.00609	CbGbCtD
Arsenic trioxide—ABCB1—Docetaxel—prostate cancer	0.00225	0.00607	CbGbCtD
Arsenic trioxide—CYP3A4—Prednisone—prostate cancer	0.00194	0.00524	CbGbCtD
Arsenic trioxide—CCND1—prostate gland—prostate cancer	0.00179	0.0329	CbGeAlD
Arsenic trioxide—ABCB1—Doxorubicin—prostate cancer	0.00167	0.00453	CbGbCtD
Arsenic trioxide—CCND1—seminal vesicle—prostate cancer	0.00151	0.0278	CbGeAlD
Arsenic trioxide—MAPK1—prostate gland—prostate cancer	0.00151	0.0277	CbGeAlD
Arsenic trioxide—CYP3A4—Etoposide—prostate cancer	0.00147	0.00398	CbGbCtD
Arsenic trioxide—TXNRD1—prostate gland—prostate cancer	0.0014	0.0258	CbGeAlD
Arsenic trioxide—CYP3A4—Docetaxel—prostate cancer	0.00135	0.00364	CbGbCtD
Arsenic trioxide—MAPK3—prostate gland—prostate cancer	0.00133	0.0245	CbGeAlD
Arsenic trioxide—CCND1—epithelium—prostate cancer	0.00131	0.0242	CbGeAlD
Arsenic trioxide—AKT1—prostate gland—prostate cancer	0.00126	0.0231	CbGeAlD
Arsenic trioxide—CCND1—renal system—prostate cancer	0.00122	0.0224	CbGeAlD
Arsenic trioxide—CCND1—urethra—prostate cancer	0.0012	0.022	CbGeAlD
Arsenic trioxide—TXNRD1—seminal vesicle—prostate cancer	0.00119	0.0218	CbGeAlD
Arsenic trioxide—MAPK3—seminal vesicle—prostate cancer	0.00113	0.0207	CbGeAlD
Arsenic trioxide—MAPK1—epithelium—prostate cancer	0.00111	0.0204	CbGeAlD
Arsenic trioxide—JUN—prostate gland—prostate cancer	0.00109	0.0201	CbGeAlD
Arsenic trioxide—IKBKB—prostate gland—prostate cancer	0.00109	0.02	CbGeAlD
Arsenic trioxide—AKT1—seminal vesicle—prostate cancer	0.00106	0.0196	CbGeAlD
Arsenic trioxide—TXNRD1—epithelium—prostate cancer	0.00103	0.019	CbGeAlD
Arsenic trioxide—MAPK1—renal system—prostate cancer	0.00103	0.0189	CbGeAlD
Arsenic trioxide—CYP3A4—Doxorubicin—prostate cancer	0.001	0.00271	CbGbCtD
Arsenic trioxide—MAPK3—epithelium—prostate cancer	0.00098	0.018	CbGeAlD
Arsenic trioxide—TXNRD1—renal system—prostate cancer	0.000956	0.0176	CbGeAlD
Arsenic trioxide—TXNRD1—urethra—prostate cancer	0.000939	0.0173	CbGeAlD
Arsenic trioxide—JUN—seminal vesicle—prostate cancer	0.000926	0.017	CbGeAlD
Arsenic trioxide—AKT1—epithelium—prostate cancer	0.000924	0.017	CbGeAlD
Arsenic trioxide—MAPK3—renal system—prostate cancer	0.000909	0.0167	CbGeAlD
Arsenic trioxide—MAPK3—urethra—prostate cancer	0.000893	0.0164	CbGeAlD
Arsenic trioxide—AKT1—renal system—prostate cancer	0.000857	0.0158	CbGeAlD
Arsenic trioxide—CYP3A4—urine—prostate cancer	0.000843	0.0155	CbGeAlD
Arsenic trioxide—AKT1—urethra—prostate cancer	0.000842	0.0155	CbGeAlD
Arsenic trioxide—JUN—epithelium—prostate cancer	0.000804	0.0148	CbGeAlD
Arsenic trioxide—CCND1—testis—prostate cancer	0.000788	0.0145	CbGeAlD
Arsenic trioxide—MAPK1—bone marrow—prostate cancer	0.000776	0.0143	CbGeAlD
Arsenic trioxide—JUN—renal system—prostate cancer	0.000746	0.0137	CbGeAlD
Arsenic trioxide—JUN—urethra—prostate cancer	0.000733	0.0135	CbGeAlD
Arsenic trioxide—IKBKB—urethra—prostate cancer	0.000729	0.0134	CbGeAlD
Arsenic trioxide—TXNRD1—bone marrow—prostate cancer	0.000723	0.0133	CbGeAlD
Arsenic trioxide—MAPK3—bone marrow—prostate cancer	0.000687	0.0126	CbGeAlD
Arsenic trioxide—MAPK1—testis—prostate cancer	0.000664	0.0122	CbGeAlD
Arsenic trioxide—AKT1—bone marrow—prostate cancer	0.000648	0.0119	CbGeAlD
Arsenic trioxide—TXNRD1—testis—prostate cancer	0.000618	0.0114	CbGeAlD
Arsenic trioxide—ABCC2—prostate gland—prostate cancer	0.000596	0.011	CbGeAlD
Arsenic trioxide—MAPK3—testis—prostate cancer	0.000587	0.0108	CbGeAlD
Arsenic trioxide—CYP1B1—prostate gland—prostate cancer	0.000583	0.0107	CbGeAlD
Arsenic trioxide—CCND1—lymph node—prostate cancer	0.000571	0.0105	CbGeAlD
Arsenic trioxide—JUN—bone marrow—prostate cancer	0.000564	0.0104	CbGeAlD
Arsenic trioxide—AKT1—testis—prostate cancer	0.000554	0.0102	CbGeAlD
Arsenic trioxide—JUN—testis—prostate cancer	0.000482	0.00887	CbGeAlD
Arsenic trioxide—MAPK1—lymph node—prostate cancer	0.000481	0.00885	CbGeAlD
Arsenic trioxide—IKBKB—testis—prostate cancer	0.00048	0.00882	CbGeAlD
Arsenic trioxide—TXNRD1—lymph node—prostate cancer	0.000448	0.00823	CbGeAlD
Arsenic trioxide—MAPK3—lymph node—prostate cancer	0.000426	0.00783	CbGeAlD
Arsenic trioxide—TXNRD1—Testosterone—Abiraterone—prostate cancer	0.000411	0.148	CbGdCrCtD
Arsenic trioxide—ABCC2—renal system—prostate cancer	0.000406	0.00747	CbGeAlD
Arsenic trioxide—AKT1—lymph node—prostate cancer	0.000402	0.00738	CbGeAlD
Arsenic trioxide—CYP1B1—renal system—prostate cancer	0.000398	0.00731	CbGeAlD
Arsenic trioxide—JUN—lymph node—prostate cancer	0.000349	0.00643	CbGeAlD
Arsenic trioxide—IKBKB—lymph node—prostate cancer	0.000348	0.0064	CbGeAlD
Arsenic trioxide—CYP1A1—epithelium—prostate cancer	0.000303	0.00557	CbGeAlD
Arsenic trioxide—CCND1—Fulvestrant—Estradiol—prostate cancer	0.000285	0.103	CbGdCrCtD
Arsenic trioxide—CYP1A1—renal system—prostate cancer	0.000281	0.00517	CbGeAlD
Arsenic trioxide—CYP1A1—urethra—prostate cancer	0.000276	0.00508	CbGeAlD
Arsenic trioxide—ABCC2—testis—prostate cancer	0.000262	0.00483	CbGeAlD
Arsenic trioxide—CYP1B1—testis—prostate cancer	0.000257	0.00473	CbGeAlD
Arsenic trioxide—TXNRD1—Estriol—Estramustine—prostate cancer	0.000243	0.0876	CbGdCrCtD
Arsenic trioxide—ABCB1—prostate gland—prostate cancer	0.000214	0.00394	CbGeAlD
Arsenic trioxide—CYP3A4—renal system—prostate cancer	0.000206	0.00379	CbGeAlD
Arsenic trioxide—TXNRD1—Estriol—Estrone—prostate cancer	0.000193	0.0696	CbGdCrCtD
Arsenic trioxide—ABCC2—lymph node—prostate cancer	0.00019	0.0035	CbGeAlD
Arsenic trioxide—CYP1B1—lymph node—prostate cancer	0.000186	0.00343	CbGeAlD
Arsenic trioxide—ABCB1—seminal vesicle—prostate cancer	0.000181	0.00333	CbGeAlD
Arsenic trioxide—TXNRD1—Testosterone—Estramustine—prostate cancer	0.000171	0.0615	CbGdCrCtD
Arsenic trioxide—TXNRD1—Estriol—Conjugated Estrogens—prostate cancer	0.00017	0.0613	CbGdCrCtD
Arsenic trioxide—TXNRD1—Teniposide—Etoposide—prostate cancer	0.000164	0.0592	CbGdCrCtD
Arsenic trioxide—ABCB1—epithelium—prostate cancer	0.000157	0.0029	CbGeAlD
Arsenic trioxide—TXNRD1—Estriol—Estradiol—prostate cancer	0.000146	0.0527	CbGdCrCtD
Arsenic trioxide—ABCB1—renal system—prostate cancer	0.000146	0.00269	CbGeAlD
Arsenic trioxide—ABCB1—urethra—prostate cancer	0.000143	0.00264	CbGeAlD
Arsenic trioxide—TXNRD1—Estriol—Ethinyl Estradiol—prostate cancer	0.000143	0.0515	CbGdCrCtD
Arsenic trioxide—TXNRD1—Testosterone—Estrone—prostate cancer	0.000136	0.0489	CbGdCrCtD
Arsenic trioxide—CYP1A1—lymph node—prostate cancer	0.000132	0.00242	CbGeAlD
Arsenic trioxide—ABCB1—bone marrow—prostate cancer	0.00011	0.00203	CbGeAlD
Arsenic trioxide—TXNRD1—Testosterone—Estradiol—prostate cancer	0.000103	0.037	CbGdCrCtD
Arsenic trioxide—ABCB1—testis—prostate cancer	9.44e-05	0.00174	CbGeAlD
Arsenic trioxide—TXNRD1—Idarubicin—Epirubicin—prostate cancer	8.57e-05	0.0309	CbGdCrCtD
Arsenic trioxide—TXNRD1—Daunorubicin—Epirubicin—prostate cancer	8.57e-05	0.0309	CbGdCrCtD
Arsenic trioxide—TXNRD1—Idarubicin—Doxorubicin—prostate cancer	7.93e-05	0.0286	CbGdCrCtD
Arsenic trioxide—TXNRD1—Daunorubicin—Doxorubicin—prostate cancer	7.93e-05	0.0286	CbGdCrCtD
Arsenic trioxide—TXNRD1—Norethindrone—Ethinyl Estradiol—prostate cancer	7.34e-05	0.0265	CbGdCrCtD
Arsenic trioxide—ABCB1—lymph node—prostate cancer	6.84e-05	0.00126	CbGeAlD
Arsenic trioxide—TXNRD1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	5.84e-05	0.021	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisone—prostate cancer	3.74e-05	0.0135	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisone—prostate cancer	3.69e-05	0.0133	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Prednisone—prostate cancer	3.69e-05	0.0133	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisone—prostate cancer	1.83e-05	0.00658	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisone—prostate cancer	1.83e-05	0.00658	CbGdCrCtD
Arsenic trioxide—MAPK1—Signaling Pathways—NOS3—prostate cancer	5.98e-07	3.87e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MDM2—prostate cancer	5.97e-07	3.86e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—KRAS—prostate cancer	5.96e-07	3.85e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—MYC—prostate cancer	5.95e-07	3.85e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PIK3CB—prostate cancer	5.95e-07	3.85e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TGFB1—prostate cancer	5.94e-07	3.84e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—EP300—prostate cancer	5.9e-07	3.81e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PTGS2—prostate cancer	5.9e-07	3.81e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ERBB2—prostate cancer	5.88e-07	3.8e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—PIK3CA—prostate cancer	5.87e-07	3.8e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SLC22A1—prostate cancer	5.87e-07	3.79e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CDKN1B—prostate cancer	5.85e-07	3.78e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—RXRA—prostate cancer	5.84e-07	3.77e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EGFR—prostate cancer	5.82e-07	3.76e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—JAK2—prostate cancer	5.82e-07	3.76e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PIK3CB—prostate cancer	5.81e-07	3.75e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—FGF2—prostate cancer	5.81e-07	3.75e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCL8—prostate cancer	5.75e-07	3.72e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EGFR—prostate cancer	5.74e-07	3.71e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CASP3—prostate cancer	5.73e-07	3.7e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NOS3—prostate cancer	5.73e-07	3.7e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL2—prostate cancer	5.72e-07	3.7e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SULT2A1—prostate cancer	5.72e-07	3.7e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—PIK3CA—prostate cancer	5.7e-07	3.68e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MTHFR—prostate cancer	5.69e-07	3.68e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MDM2—prostate cancer	5.68e-07	3.67e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—KRAS—prostate cancer	5.67e-07	3.67e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—KRAS—prostate cancer	5.67e-07	3.66e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MYC—prostate cancer	5.67e-07	3.66e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TGFB1—prostate cancer	5.65e-07	3.65e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—PIK3CA—prostate cancer	5.64e-07	3.65e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MED12—prostate cancer	5.63e-07	3.64e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—COMT—prostate cancer	5.62e-07	3.64e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CDKN1B—prostate cancer	5.62e-07	3.63e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTP1—prostate cancer	5.6e-07	3.62e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ERBB2—prostate cancer	5.6e-07	3.62e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PPARA—prostate cancer	5.58e-07	3.61e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GNG5—prostate cancer	5.58e-07	3.61e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCL8—prostate cancer	5.58e-07	3.61e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCND1—prostate cancer	5.58e-07	3.6e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—JAK2—prostate cancer	5.57e-07	3.6e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EGFR—prostate cancer	5.54e-07	3.58e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PIK3CB—prostate cancer	5.52e-07	3.57e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CTNNB1—prostate cancer	5.52e-07	3.57e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ITPR1—prostate cancer	5.51e-07	3.56e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CASP3—prostate cancer	5.51e-07	3.56e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—KRAS—prostate cancer	5.5e-07	3.56e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL2—prostate cancer	5.5e-07	3.55e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—PIK3CA—prostate cancer	5.47e-07	3.54e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL6—prostate cancer	5.47e-07	3.54e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CDKN1B—prostate cancer	5.45e-07	3.52e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MDM2—prostate cancer	5.43e-07	3.51e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—KRAS—prostate cancer	5.42e-07	3.51e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MMP9—prostate cancer	5.42e-07	3.5e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CDKN1A—prostate cancer	5.4e-07	3.49e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PTEN—prostate cancer	5.38e-07	3.48e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NCOA3—prostate cancer	5.38e-07	3.48e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCND1—prostate cancer	5.36e-07	3.46e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ERBB2—prostate cancer	5.36e-07	3.46e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CASP3—prostate cancer	5.34e-07	3.45e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL2—prostate cancer	5.33e-07	3.45e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCL8—prostate cancer	5.31e-07	3.43e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CTNNB1—prostate cancer	5.31e-07	3.43e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL6—prostate cancer	5.31e-07	3.43e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PIK3CB—prostate cancer	5.29e-07	3.42e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CAV1—prostate cancer	5.25e-07	3.39e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—KRAS—prostate cancer	5.23e-07	3.38e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—PIK3CA—prostate cancer	5.21e-07	3.37e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—PIK3CA—prostate cancer	5.21e-07	3.37e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—TYMS—prostate cancer	5.2e-07	3.36e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MMP9—prostate cancer	5.2e-07	3.36e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL6—prostate cancer	5.2e-07	3.36e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCND1—prostate cancer	5.2e-07	3.36e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CDKN1A—prostate cancer	5.18e-07	3.35e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CDKN1B—prostate cancer	5.18e-07	3.35e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PTEN—prostate cancer	5.17e-07	3.34e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CTNNB1—prostate cancer	5.15e-07	3.33e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTM1—prostate cancer	5.14e-07	3.32e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PTEN—prostate cancer	5.14e-07	3.32e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EP300—prostate cancer	5.13e-07	3.32e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HPGDS—prostate cancer	5.13e-07	3.32e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP2C19—prostate cancer	5.1e-07	3.29e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CASP3—prostate cancer	5.08e-07	3.28e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCL8—prostate cancer	5.08e-07	3.28e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL2—prostate cancer	5.07e-07	3.28e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—PIK3CA—prostate cancer	5.05e-07	3.27e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—LPL—prostate cancer	5.05e-07	3.26e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL6—prostate cancer	5.05e-07	3.26e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MMP9—prostate cancer	5.05e-07	3.26e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CDKN1A—prostate cancer	5.03e-07	3.25e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PTEN—prostate cancer	5.02e-07	3.24e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.02e-07	3.24e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL6—prostate cancer	5e-07	3.23e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SRC—prostate cancer	4.99e-07	3.23e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—PIK3CA—prostate cancer	4.98e-07	3.22e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ACHE—prostate cancer	4.98e-07	3.22e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTT1—prostate cancer	4.98e-07	3.22e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CDKN1B—prostate cancer	4.96e-07	3.21e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCND1—prostate cancer	4.95e-07	3.2e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EP300—prostate cancer	4.93e-07	3.19e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.92e-07	3.18e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—EP300—prostate cancer	4.9e-07	3.17e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CTNNB1—prostate cancer	4.9e-07	3.17e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AKT1—prostate cancer	4.89e-07	3.16e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP1A1—prostate cancer	4.88e-07	3.15e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VEGFA—prostate cancer	4.86e-07	3.14e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CASP3—prostate cancer	4.86e-07	3.14e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL2—prostate cancer	4.85e-07	3.14e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL6—prostate cancer	4.85e-07	3.13e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ERCC2—prostate cancer	4.84e-07	3.13e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—STAT3—prostate cancer	4.82e-07	3.11e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—PIK3CA—prostate cancer	4.81e-07	3.11e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MMP9—prostate cancer	4.8e-07	3.1e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—AKT1—prostate cancer	4.8e-07	3.1e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SRC—prostate cancer	4.8e-07	3.1e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.78e-07	3.09e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EP300—prostate cancer	4.78e-07	3.09e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CDKN1A—prostate cancer	4.78e-07	3.09e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3CG—prostate cancer	4.78e-07	3.09e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PTEN—prostate cancer	4.77e-07	3.09e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PRKACB—prostate cancer	4.76e-07	3.08e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCND1—prostate cancer	4.73e-07	3.06e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.71e-07	3.04e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CTNNB1—prostate cancer	4.69e-07	3.03e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VEGFA—prostate cancer	4.67e-07	3.02e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AKT1—prostate cancer	4.66e-07	3.01e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SRC—prostate cancer	4.65e-07	3.01e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—STAT3—prostate cancer	4.63e-07	2.99e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IL6—prostate cancer	4.61e-07	2.98e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL6—prostate cancer	4.61e-07	2.98e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MMP9—prostate cancer	4.59e-07	2.97e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CDKN1A—prostate cancer	4.58e-07	2.96e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PTEN—prostate cancer	4.57e-07	2.95e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EP300—prostate cancer	4.55e-07	2.94e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MTHFR—prostate cancer	4.55e-07	2.94e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VEGFA—prostate cancer	4.53e-07	2.93e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—INS—prostate cancer	4.53e-07	2.93e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NCOA2—prostate cancer	4.49e-07	2.9e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—STAT3—prostate cancer	4.49e-07	2.9e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IL6—prostate cancer	4.48e-07	2.89e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MYC—prostate cancer	4.47e-07	2.89e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—AKT1—prostate cancer	4.47e-07	2.89e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TGFB1—prostate cancer	4.46e-07	2.88e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PPARA—prostate cancer	4.46e-07	2.88e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—AKT1—prostate cancer	4.45e-07	2.87e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CREBBP—prostate cancer	4.43e-07	2.87e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SRC—prostate cancer	4.43e-07	2.86e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL6—prostate cancer	4.41e-07	2.85e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EGFR—prostate cancer	4.38e-07	2.83e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PIK3CA—prostate cancer	4.36e-07	2.82e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EP300—prostate cancer	4.36e-07	2.81e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VEGFA—prostate cancer	4.31e-07	2.79e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MYC—prostate cancer	4.3e-07	2.78e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TGFB1—prostate cancer	4.29e-07	2.77e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SLC5A5—prostate cancer	4.28e-07	2.77e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—STAT3—prostate cancer	4.27e-07	2.76e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IL6—prostate cancer	4.26e-07	2.75e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—AKT1—prostate cancer	4.26e-07	2.75e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SRC—prostate cancer	4.24e-07	2.74e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EGFR—prostate cancer	4.2e-07	2.72e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3CD—prostate cancer	4.2e-07	2.72e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CAV1—prostate cancer	4.19e-07	2.71e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP2E1—prostate cancer	4.18e-07	2.7e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MYC—prostate cancer	4.17e-07	2.69e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TGFB1—prostate cancer	4.16e-07	2.69e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NQO1—prostate cancer	4.14e-07	2.67e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—KRAS—prostate cancer	4.13e-07	2.67e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—AKT1—prostate cancer	4.13e-07	2.67e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VEGFA—prostate cancer	4.13e-07	2.67e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—STAT3—prostate cancer	4.08e-07	2.64e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EGFR—prostate cancer	4.08e-07	2.64e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TH—prostate cancer	4.08e-07	2.63e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—AKT1—prostate cancer	4.07e-07	2.63e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—KRAS—prostate cancer	3.97e-07	2.57e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—NOS3—prostate cancer	3.97e-07	2.57e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MYC—prostate cancer	3.97e-07	2.56e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.96e-07	2.56e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TGFB1—prostate cancer	3.96e-07	2.56e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—AKT1—prostate cancer	3.93e-07	2.54e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EGFR—prostate cancer	3.88e-07	2.51e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—KRAS—prostate cancer	3.85e-07	2.49e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GGT1—prostate cancer	3.84e-07	2.48e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3CG—prostate cancer	3.82e-07	2.47e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PIK3CA—prostate cancer	3.8e-07	2.45e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MYC—prostate cancer	3.8e-07	2.45e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TGFB1—prostate cancer	3.79e-07	2.45e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NCOA1—prostate cancer	3.78e-07	2.44e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.73e-07	2.41e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EGFR—prostate cancer	3.71e-07	2.4e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—prostate cancer	3.67e-07	2.37e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—KRAS—prostate cancer	3.67e-07	2.37e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3CB—prostate cancer	3.66e-07	2.37e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PIK3CA—prostate cancer	3.65e-07	2.36e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PTGS2—prostate cancer	3.63e-07	2.35e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PIK3CA—prostate cancer	3.63e-07	2.34e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—INS—prostate cancer	3.62e-07	2.34e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—RXRA—prostate cancer	3.6e-07	2.33e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CREBBP—prostate cancer	3.54e-07	2.29e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PIK3CA—prostate cancer	3.54e-07	2.29e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—prostate cancer	3.53e-07	2.28e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—KRAS—prostate cancer	3.51e-07	2.27e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—COMT—prostate cancer	3.47e-07	2.24e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTP1—prostate cancer	3.45e-07	2.23e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—prostate cancer	3.42e-07	2.21e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ITPR1—prostate cancer	3.39e-07	2.19e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PIK3CA—prostate cancer	3.37e-07	2.18e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL6—prostate cancer	3.36e-07	2.17e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3CD—prostate cancer	3.36e-07	2.17e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—prostate cancer	3.26e-07	2.11e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL6—prostate cancer	3.23e-07	2.09e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PIK3CA—prostate cancer	3.22e-07	2.08e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TYMS—prostate cancer	3.21e-07	2.07e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—NOS3—prostate cancer	3.17e-07	2.05e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTM1—prostate cancer	3.17e-07	2.05e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PTEN—prostate cancer	3.17e-07	2.05e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL6—prostate cancer	3.13e-07	2.03e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—prostate cancer	3.12e-07	2.01e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—LPL—prostate cancer	3.11e-07	2.01e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AKT1—prostate cancer	3.1e-07	2.01e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—EP300—prostate cancer	3.02e-07	1.95e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP1A1—prostate cancer	3e-07	1.94e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL6—prostate cancer	2.98e-07	1.93e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ERCC2—prostate cancer	2.98e-07	1.93e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—AKT1—prostate cancer	2.96e-07	1.92e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3CB—prostate cancer	2.93e-07	1.89e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PTGS2—prostate cancer	2.9e-07	1.87e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AKT1—prostate cancer	2.89e-07	1.87e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL6—prostate cancer	2.85e-07	1.84e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MTHFR—prostate cancer	2.8e-07	1.81e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AKT1—prostate cancer	2.75e-07	1.78e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PPARA—prostate cancer	2.75e-07	1.78e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AKT1—prostate cancer	2.63e-07	1.7e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CAV1—prostate cancer	2.58e-07	1.67e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PTEN—prostate cancer	2.53e-07	1.63e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—EP300—prostate cancer	2.41e-07	1.56e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.35e-07	1.52e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3CA—prostate cancer	2.23e-07	1.44e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—INS—prostate cancer	2.23e-07	1.44e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CREBBP—prostate cancer	2.18e-07	1.41e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.07e-07	1.34e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NOS3—prostate cancer	1.95e-07	1.26e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AKT1—prostate cancer	1.83e-07	1.18e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.8e-07	1.17e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PTGS2—prostate cancer	1.79e-07	1.15e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3CA—prostate cancer	1.78e-07	1.15e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PTEN—prostate cancer	1.56e-07	1.01e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—EP300—prostate cancer	1.49e-07	9.6e-07	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AKT1—prostate cancer	1.46e-07	9.42e-07	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.1e-07	7.1e-07	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKT1—prostate cancer	8.98e-08	5.8e-07	CbGpPWpGaD
